Clinical features of individuals with first episode of PRP occurring after commencement of flash monitoring
| Age range (years) | Diabetes duration (years) | Baseline HbA1c (mmol/mol/%) | Smoking status | Urine albumin status | HbA1c change at next follow-up (mmol/mol/%) | Severe hypoglycemia in previous year | HbA1c change at final follow-up | MDI/CSII | Baseline retinopathy status | Days flash monitoring prior to PRP | Final retinopathy status | Days flash monitoring to final retinopathy status | |
| 1 | 30–40 | 8 | 64/8.0 | NA | NA | −6/−0.6 | No | NA | CSII | Proliferative | 155 | Mild.background | 1241 |
| 2 | 30–40 | 14 | 83/9.7 | Never | Normal | +4/+0.4 | NA | −10/−0.9 | MDI | None | 635 | Proliferative | 678 |
| 3 | 30–40 | 6 | 80/9.5 | Ex | Normal | −24/−2.2 | No | −31/−2.8 | MDI | Mild background | 387 | Non-proliferative | 927 |
| 4 | 50–60 | 32 | 66/8.2 | Current | Normal | −8/−0.7 | No | NA | MD | Non-proliferative | 1076 | Proliferative | 1076 |
| 5 | 40–50 | 21 | 57/7.4 | Ex | Normal | −2/−0.2 | NA | +12/1.1 | MDI | Mild non-proliferative | 767 | Proliferative | 965 |
| 6 | 60–70 | 8 | 84/9.8 | Ex | Normal | −22/−2.0 | NA | 0/0 | MDI | Mild background | 165 | NA | NA |
| 7 | 30–40 | 14 | 82/9.7 | NA | NA | −10/−0.9 | NA | 0/0 | MDI | Mild background | 284 | Proliferative | 1228 |
CSII, continuous subcutaneous insulin infusion; HbA1c, glycated hemoglobin; MDI, multiple daily injection; NA, not available; PRP, panretinal photocoagulation.